ARCUTIS BIOTHERAPEUTICS INC shareholders Q3 2023

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.

ARCUTIS BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$46,113,2723.06%
Pivotal bioVenture Partners Investment Advisor LLC 1,105,309$5,869,1912.34%
Bain Capital Life Sciences Investors, LLC 3,000,000$15,930,0001.78%
Sio Capital Management, LLC 635,969$3,376,9951.04%
Rubric Capital Management LP 5,034,530$26,733,3541.00%
Tejara Capital Ltd 309,179$1,641,7400.93%
AlphaCentric Advisors LLC 165,000$876,1500.50%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,135,227$6,028,0550.33%
Orbimed Advisors 1,914,479$10,165,8830.22%
Two Seas Capital LP 164,807$875,1250.18%
PDT Partners, LLC 195,081$1,035,8800.13%
Polar Capital Holdings Plc 3,117,944$16,556,2830.12%
GW&K Investment Management, LLC 2,069,293$10,9880.11%
Symmetry Investments LP 85,000$4510.09%
Perceptive Advisors 300,000$2,622,5000.09%
Woodline Partners LP 1,104,244$5,863,5360.07%
Symmetry Investments LP 58,200$3090.06%
Regency Capital Management Inc.\DE 13,000$69,0300.06%
FISHMAN JAY A LTD/MI 87,000$461,9700.06%
Hennion & Walsh Asset Management, Inc. 95,308$506,0850.03%
External links

This page lists ARCUTIS BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view ARCUTIS BIOTHERAPEUTICS INC's shareholder history, click here.